Did you miss our Conference Call on IBM? Watch the replay here. HIDE

AstraZeneca (AZN)

Add to Watchlists Create an Alert
72.79 -0.40  -0.55% NYSE Jul 31, 4:59PM BATS Real time Currency in USD

AstraZeneca Cash from Investing (Quarterly):

-3.777B for March 31, 2014

View 4,000+ financial data types

View Full Chart

AstraZeneca Cash from Investing (Quarterly) Chart

Export Data
Save Image

AstraZeneca Historical Cash from Investing (Quarterly) Data

View and export this data going back to 1995. Start your YCharts Lite Membership
Export Data Date Range:
Viewing of   First  Previous First  Previous   Next  Last Next   Last
Data for this Date Range  
March 31, 2014 -3.777B
Dec. 31, 2013 -1.004B
Sept. 30, 2013 -283.00M
June 30, 2013 -1.238B
March 31, 2013 -364.00M
Dec. 31, 2012 -514.00M
Sept. 30, 2012 -3.291B
June 30, 2012 1.353B
March 31, 2012 593.00M
Dec. 31, 2011 -3.58B
Sept. 30, 2011 1.172B
June 30, 2011 286.00M
March 31, 2011 100.00M
Dec. 31, 2010 -452.00M
Sept. 30, 2010 1.365B
June 30, 2010 -2.032B
March 31, 2010 -1.107B
Dec. 31, 2009 -1.904B
Sept. 30, 2009 -484.00M
June 30, 2009 -162.00M
March 31, 2009 74.00M
Dec. 31, 2008 -472.00M
Sept. 30, 2008 2.712B
June 30, 2008 -3.199B
March 31, 2008 -2.937B
   
Dec. 31, 2007 -427.00M
Sept. 30, 2007 649.00M
June 30, 2007 -14.49B
March 31, 2007 -616.00M
Dec. 31, 2006 285.00M
Sept. 30, 2006 1.357B
June 30, 2006 -11.00M
March 31, 2006 -1.903B
Dec. 31, 2005 -561.00M
Sept. 30, 2005 -1.069B
June 30, 2005 477.00M
March 31, 2005 -29.00M
Dec. 31, 2004 1.664B
Sept. 30, 2004 -320.00M
June 30, 2004 -78.00M
March 31, 2004 -296.00M
Dec. 31, 2003 70.00M
Sept. 30, 2003 1.00M
June 30, 2003 -593.00M
March 31, 2003 -330.00M
Dec. 31, 2002 -509.00M
Sept. 30, 2002 -116.00M
June 30, 2002 -633.00M
March 31, 2002 -285.00M
Dec. 31, 2001 -553.00M

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.

About Cash From Investing

An item on a company's cash flow statement. Lists aggregate change in cash position resulting from investing activities. Includes the company's cash inflows and outflows from investments in financial markets and the sale of capital assets.
Learn More

Get data for
Advertisement

AZN Cash from Investing (Quarterly) Benchmarks

Companies
GlaxoSmithKline -813.07M
Pfizer -98.00M
AbbVie -797.00M

AZN Cash from Investing (Quarterly) Range, Past 5 Years

Minimum -3.777B Mar 2014
Maximum 1.365B Sep 2010
Average -797.95M

AZN Cash from Investing (Quarterly) Excel Add-In Codes

  • Metric Code: cash_investing
  • Latest data point: =YCP("AZN", "cash_investing")
  • Last 5 data points: =YCS("AZN", "cash_investing", -4)

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.

Advertisement

Already registered? Click here to sign in.

Access watchlists and custom data alerts.
Start your free account.

required
required
required
required
required
Get Started Now
document.write('');

{{root.upsell.info.feature_headline}}.
Upgrade to {{root.upsell.info.tier_name}}. Start your {{root.upsell.info.tier_name}} Membership

{{root.upsell.info.feature_description}}

{{root.upsell.info.is_upgrade ? "Upgrade Now" : "Start My Free Trial"}}

Already a {{root.upsell.info.tier_name}} Member? Sign in here.